Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX Peramivir — Total trade receivables

Similar metrics at other companies

Churchill Downs logo
CHDNTrade receivables — Accounts receivable
$33M-9.1%
Veracyte logo
VCYTBiopharmaceutical and other revenue — Accounts receivable
$1.1M-78.4%
Fortrea Holdings Inc. logo
FTREAccounts receivable and unbilled services, net
$619.6M-15.0%
PepsiCo logo
PEPTrade receivables
$9.27B+9.2%
NovoCure logo
NVCRReceivables and prepaid expenses
$53.13M+56.1%
Constellium logo
CSTMTrade receivables and other, net
$723M+48.8%

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNet.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's peramivir — total trade receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's peramivir — total trade receivables?
BioCryst Pharmaceuticals (BCRX) reported peramivir — total trade receivables of $381K in Q1 2026.
How has BioCryst Pharmaceuticals's peramivir — total trade receivables changed year-over-year?
BioCryst Pharmaceuticals's peramivir — total trade receivables decreased by 68.3% year-over-year, from $1.2M to $381K.
What does peramivir — total trade receivables mean?
This metric represents the total outstanding balance owed to the company by customers for Peramivir product sales that have been invoiced but not yet collected. It serves as a key indicator of the company's credit risk exposure and the efficiency of its accounts receivable collection process for this specific therapeutic product. Monitoring this balance helps investors assess the liquidity generated from product sales and the potential for future cash inflows.